- Home
- Publications
- Publication Search
- Publication Details
Title
Macrophage cathepsin K promotes prostate tumor progression in bone
Authors
Keywords
-
Journal
ONCOGENE
Volume 32, Issue 12, Pages 1580-1593
Publisher
Springer Nature
Online
2012-05-21
DOI
10.1038/onc.2012.166
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Chemokine CCL2 Increases Prostate Tumor Growth and Bone Metastasis through Macrophage and Osteoclast Recruitment
- (2015) Kosuke Mizutani et al. NEOPLASIA
- Osteoclasts Have Multiple Roles in Bone in Addition to Bone Resorption
- (2012) Brendan Boyce et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Enhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblasts
- (2011) A Shiirevnyamba et al. BRITISH JOURNAL OF CANCER
- Contemporary Therapeutic Approaches Targeting Bone Complications in Prostate Cancer
- (2011) Richard J. Lee et al. Clinical Genitourinary Cancer
- Emerging Therapies to Prevent Skeletal Morbidity in Men With Prostate Cancer
- (2011) Philip J. Saylor et al. JOURNAL OF CLINICAL ONCOLOGY
- Proteolytic networks in cancer
- (2011) Steven D. Mason et al. TRENDS IN CELL BIOLOGY
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
- (2011) David G. DeNardo et al. Cancer Discovery
- Infiltration of tumour-associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer
- (2010) Norio Nonomura et al. BJU INTERNATIONAL
- Treatment and prevention of bone complications from prostate cancer
- (2010) Richard J. Lee et al. BONE
- Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis
- (2010) Conor C. Lynch BONE
- Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis
- (2010) Tsu-Yi Chao et al. CLINICA CHIMICA ACTA
- The Cathepsin K Inhibitor Odanacatib Suppresses Bone Resorption in Women With Breast Cancer and Established Bone Metastases: Results of a 4-Week, Double-Blind, Randomized, Controlled Trial
- (2010) Anders Bonde Jensen et al. Clinical Breast Cancer
- Future of anticathepsin K drugs: dual therapy for skeletal disease and atherosclerosis?
- (2010) Izabela Podgorski Future Medicinal Chemistry
- IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
- (2010) V. Gocheva et al. GENES & DEVELOPMENT
- Regression of prostate tumors upon combination of hormone ablation therapy and celecoxib in vivo
- (2010) Parisa Abedinpour et al. PROSTATE
- The Effects of COX-2 Inhibitor During Osteogenic Differentiation of Bone Marrow-Derived Human Mesenchymal Stem Cells
- (2010) Dong Suk Yoon et al. STEM CELLS AND DEVELOPMENT
- Bone Marrow-Derived Cathepsin K Cleaves SPARC in Bone Metastasis
- (2009) Izabela Podgorski et al. AMERICAN JOURNAL OF PATHOLOGY
- MCP-1 expressed by osteoclasts stimulates osteoclastogenesis in an autocrine/paracrine manner
- (2009) Kana Miyamoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Pharmacological inhibitors to identify roles of cathepsin K in cell-based studies: a comparison of available tools
- (2009) Sylvie Desmarais et al. BIOLOGICAL CHEMISTRY
- Reduced Risk of Bone Metastasis for Patients With Breast Cancer Who Use COX-2 Inhibitors
- (2009) Matias E. Valsecchi et al. Clinical Breast Cancer
- CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis
- (2009) Jian Zhang et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Cathepsin K inhibitors for osteoporosis and potential off-target effects
- (2009) Dieter Brömme et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The effect of selective cyclooxygenase-2 inhibitor on human osteoclast precursors to influence osteoclastogenesis in vitro
- (2009) Masayuki Kawashima et al. Modern Rheumatology
- Intraosseous injection of RM1 murine prostate cancer cells promotes rapid osteolysis and periosteal bone deposition
- (2008) N. Patrick McCabe et al. CLINICAL & EXPERIMENTAL METASTASIS
- Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model
- (2008) Haiyen E. Zhau et al. CLINICAL & EXPERIMENTAL METASTASIS
- Proteolytic processing of chemokines: Implications in physiological and pathological conditions
- (2008) M WOLF et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Cathepsin K Activity-dependent Regulation of Osteoclast Actin Ring Formation and Bone Resorption
- (2008) Susan R. Wilson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of a Nonbasic, Nitrile-Containing Cathepsin K Inhibitor (MK-1256) that is Efficacious in a Monkey Model of Osteoporosis
- (2008) Jöel Robichaud et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Osteoclasts Are Active in Bone Forming Metastases of Prostate Cancer Patients
- (2008) Ilaria Roato et al. PLoS One
- Cathepsin K-Dependent Toll-Like Receptor 9 Signaling Revealed in Experimental Arthritis
- (2008) M. Asagiri et al. SCIENCE
- Osteoclast targeted therapy for prostate cancer: Bisphosphonates and beyond
- (2008) Matthew R. Smith UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Cysteine cathepsin proteases as pharmacological targets in cancer
- (2007) Carmela Palermo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started